Latest External beam radiotherapy Stories
Patients treated with IMRT for head and neck cancer report an increasingly better quality of life post-treatment when compared to patients receiving other forms of radiation therapy.
Proton therapy, a type of external beam radiation therapy, is a safe and effective treatment for prostate cancer.
Men with localized prostate cancer treated with a newer technology, intensity modulated radiation therapy (IMRT), have more than a quarter (26 percent) fewer late bowel and rectal side effects and a statistically improved lower dose of radiation to the bladder and rectum, compared to those who undergo 3D-CRT.
A shorter course of radiation treatment that delivers higher doses of radiation per day in fewer days (hypofractionation) is as effective in decreasing intermediate to high-risk prostate cancer from returning as conventional radiation therapy at five years after treatment.
PALO ALTO, Calif. and WALTHAM, Mass., May 12, 2011 /PRNewswire/ -- Varian Medical Systems, Inc. (NYSE: VAR), the world's leading supplier of medical technology for treating cancer with radiotherapy, and privately-held Augmenix, Inc.
SAN DIEGO, Nov.
SAN DIEGO, Oct. 28 /PRNewswire/ -- ASTRO Booth # 201 -- Varian Medical Systems (NYSE: VAR) will highlight its new TrueBeam(TM) system for fast, powerful and efficient cancer treatments at the 52nd annual meeting of the American Society for Radiation Oncology (ASTRO) meeting in San Diego next week.
Men with prostate cancer treated with a specialized type of radiation called intensity modulated radiation therapy (IMRT) have fewer gastrointestinal complications compared to patients treated with conventional three-dimensional conformal radiotherapy (3D-CRT).
These guidelines were released as educational tools to assist practitioners in providing appropriate, effective and safe medical care for patients.
Men who receive a â€œboostâ€ of proton therapy after receiving a standard course of X-ray radiation therapy have fewer recurrences of their prostate cancer compared to men who did not receive the extra dose of proton radiation.